Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Dalton Transactions (Cambridge, England : 2003)
|
December 22, 2009
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity
Teresa Gianferrara, Ioannis Bratsos, Elisabetta Iengo, et al.
Chemmedchem
|
March 29, 2014
Towards matched pairs of porphyrin-Re(I) /(99m) Tc(I) conjugates that combine photodynamic activity with fluorescence and radio imaging
Teresa Gianferrara, Cinzia Spagnul, Roger Alberto, et al.
Inorganic Chemistry
|
July 27, 2013
New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium
Jakob Kljun, Ioannis Bratsos, Enzo Alessio, et al.
Inorganic Chemistry
|
July 15, 2026
Impact of Bipyridine and Phenanthroline Incorporation into the Macropa Scaffold on Ba(II)/Ra(II) Chelation
Ileana Merdžo, Clarisse Brossard, Nicolas Lepareur, et al.
Chemmedchem
|
September 3, 2015
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates
Giuliana Mion, Teresa Gianferrara, Alberta Bergamo, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 12, 2024
[Gd(HB-DO3A)]: Equilibrium, Dissociation Kinetic and Structural Differences in a Simple Homolog of [Gd(HP-DO3A)] (Prohance<sup>®</sup>)
Silvia Versolatto, Mariangela Boccalon, Nicol Guidolin, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)
Aldrik H Velders, Alberta Bergamo, Enzo Alessio, et al.
Dalton Transactions (Cambridge, England : 2003)
|
July 1, 2014
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
Serena Pillozzi, Luca Gasparoli, Matteo Stefanini, et al.
Journal of Inorganic Biochemistry
|
January 20, 2004
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation
Marina Bacac, Anna C G Hotze, Karlijn van der Schilden, et al.
Investigational New Drugs
|
October 26, 2014
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen, Sjaak A Burgers, Paul Baas, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Dalton Transactions (Cambridge, England : 2003)
|
December 22, 2009
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity
Teresa Gianferrara, Ioannis Bratsos, Elisabetta Iengo, et al.
Chemmedchem
|
March 29, 2014
Towards matched pairs of porphyrin-Re(I) /(99m) Tc(I) conjugates that combine photodynamic activity with fluorescence and radio imaging
Teresa Gianferrara, Cinzia Spagnul, Roger Alberto, et al.
Inorganic Chemistry
|
July 27, 2013
New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium
Jakob Kljun, Ioannis Bratsos, Enzo Alessio, et al.
Inorganic Chemistry
|
July 15, 2026
Impact of Bipyridine and Phenanthroline Incorporation into the Macropa Scaffold on Ba(II)/Ra(II) Chelation
Ileana Merdžo, Clarisse Brossard, Nicolas Lepareur, et al.
Chemmedchem
|
September 3, 2015
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates
Giuliana Mion, Teresa Gianferrara, Alberta Bergamo, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 12, 2024
[Gd(HB-DO3A)]: Equilibrium, Dissociation Kinetic and Structural Differences in a Simple Homolog of [Gd(HP-DO3A)] (Prohance<sup>®</sup>)
Silvia Versolatto, Mariangela Boccalon, Nicol Guidolin, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)
Aldrik H Velders, Alberta Bergamo, Enzo Alessio, et al.
Dalton Transactions (Cambridge, England : 2003)
|
July 1, 2014
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
Serena Pillozzi, Luca Gasparoli, Matteo Stefanini, et al.
Journal of Inorganic Biochemistry
|
January 20, 2004
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation
Marina Bacac, Anna C G Hotze, Karlijn van der Schilden, et al.
Investigational New Drugs
|
October 26, 2014
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen, Sjaak A Burgers, Paul Baas, et al.
Page
of 7